INmune Bio Switches Accounting Firm

Summary

INmune Bio Inc. has replaced its independent registered public accounting firm because Marcum LLP was dismissed following its acquisition by CBIZ CPAs P.C. The decision was approved by the audit committee after Marcum’s audit report expressed significant doubt about INmune Bio’s ability to continue as a going concern. CBIZ CPAs will serve as the auditor for the fiscal year ending December 31, 2025. There were no disagreements affecting the financial statements between INmune Bio and Marcum.Reuters

Impact Analysis

This event is classified at the company level as it directly pertains to INmune Bio’s corporate governance and financial oversight. The replacement of the auditor may affect investor confidence due to the previous auditor’s concerns about the company’s ongoing operations. Investors may perceive risks regarding INmune Bio’s financial stability and future prospects. Opportunities could arise if the new auditor provides a more reassuring outlook, potentially stabilizing the stock price. However, risks remain if the company’s operational issues persist, impacting its long-term viability. The involvement of CBIZ CPAs P.C., a reputable firm, could help mitigate some concerns.Reuters